https://www.selleckchem.com/pr....oducts/liraglutide.h
Rapid spread of coronavirus disease 2019 (COVID-19) has affected people with intellectual disability disproportionately. Existing data does not provide enough information to understand factors associated with increased deaths in those with intellectual disability. Establishing who is at high risk is important in developing prevention strategies, given risk factors or comorbidities in people with intellectual disability may be different to those in the general population. To identify comorbidities, demographic and clinical factors of
Like
Comment
Share
